104 related articles for article (PubMed ID: 2328790)
1. Prognostic factors in idiopathic myelofibrosis: a simple scoring system with prognostic significance.
Hasselbalch H; Jensen BA
Eur J Haematol; 1990 Mar; 44(3):172-8. PubMed ID: 2328790
[TBL] [Abstract][Full Text] [Related]
2. Identification of 'short-lived' and 'long-lived' patients at presentation of idiopathic myelofibrosis.
Cervantes F; Pereira A; Esteve J; Rafel M; Cobo F; Rozman C; Montserrat E
Br J Haematol; 1997 Jun; 97(3):635-40. PubMed ID: 9207412
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.
Iványi JL; Mahunka M; Papp A; Kiss A; Telek B
Haematologia (Budap); 1994; 26(2):75-86. PubMed ID: 7890265
[TBL] [Abstract][Full Text] [Related]
4. Chronic idiopathic myelofibrosis: prognostic impact of myelofibrosis and clinical parameters on event-free survival in 122 patients who presented in prefibrotic and fibrotic stages. A retrospective study identifying subgroups of different prognoses by using the RECPAM method.
Kreft A; Weiss M; Wiese B; Choritz H; Buhr T; Büsche G; Georgii A
Ann Hematol; 2003 Oct; 82(10):605-11. PubMed ID: 14564478
[TBL] [Abstract][Full Text] [Related]
5. Age and hemoglobin level emerge as most important clinical prognostic parameters in patients with osteomyelofibrosis: introduction of a simplified prognostic score.
Strasser-Weippl K; Steurer M; Kees M; Augustin F; Tzankov A; Dirnhofer S; Fiegl M; Simonitsch-Klupp I; Zojer N; Gisslinger H; Ludwig H
Leuk Lymphoma; 2006 Mar; 47(3):441-50. PubMed ID: 16396767
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors in myelofibrosis.
Manoharan A; Smart RC; Pitney WR
Pathology; 1982 Oct; 14(4):455-61. PubMed ID: 7155637
[TBL] [Abstract][Full Text] [Related]
7. Idiopathic myelofibrosis--an update with particular reference to clinical aspects and prognosis.
Hasselbalch HC
Int J Clin Lab Res; 1993; 23(3):124-38. PubMed ID: 8400333
[TBL] [Abstract][Full Text] [Related]
8. New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.
Cervantes F; Dupriez B; Pereira A; Passamonti F; Reilly JT; Morra E; Vannucchi AM; Mesa RA; Demory JL; Barosi G; Rumi E; Tefferi A
Blood; 2009 Mar; 113(13):2895-901. PubMed ID: 18988864
[TBL] [Abstract][Full Text] [Related]
9. Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases.
Reilly JT; Snowden JA; Spearing RL; Fitzgerald PM; Jones N; Watmore A; Potter A
Br J Haematol; 1997 Jul; 98(1):96-102. PubMed ID: 9233570
[TBL] [Abstract][Full Text] [Related]
10. Primary myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis.
Thiele J; Steinberg T; Zankovich R; Fischer R
Anticancer Res; 1989; 9(2):429-35. PubMed ID: 2751268
[TBL] [Abstract][Full Text] [Related]
11. Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients.
Visani G; Finelli C; Castelli U; Petti MC; Ricci P; Vianelli N; Gianni L; Zuffa E; Aloe Spiriti MA; Latagliata R
Br J Haematol; 1990 May; 75(1):4-9. PubMed ID: 2375922
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features and prognostic factors in primary myelofibrosis patients under 45 years old].
Lu L; Xiao ZJ; Chen HS; Lin H; Han ZC
Zhonghua Xue Ye Xue Za Zhi; 2005 May; 26(5):281-4. PubMed ID: 15949290
[TBL] [Abstract][Full Text] [Related]
13. Validation and comparison of contemporary prognostic models in primary myelofibrosis: analysis based on 334 patients from a single institution.
Tefferi A; Huang J; Schwager S; Li CY; Wu W; Pardanani A; Mesa RA
Cancer; 2007 May; 109(10):2083-8. PubMed ID: 17407134
[TBL] [Abstract][Full Text] [Related]
14. DIPSS plus: a refined Dynamic International Prognostic Scoring System for primary myelofibrosis that incorporates prognostic information from karyotype, platelet count, and transfusion status.
Gangat N; Caramazza D; Vaidya R; George G; Begna K; Schwager S; Van Dyke D; Hanson C; Wu W; Pardanani A; Cervantes F; Passamonti F; Tefferi A
J Clin Oncol; 2011 Feb; 29(4):392-7. PubMed ID: 21149668
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors in agnogenic myeloid metaplasia: a report on 195 cases with a new scoring system.
Dupriez B; Morel P; Demory JL; Lai JL; Simon M; Plantier I; Bauters F
Blood; 1996 Aug; 88(3):1013-8. PubMed ID: 8704209
[TBL] [Abstract][Full Text] [Related]
16. Karyotype complements the International Prognostic Scoring System for primary myelofibrosis.
Hussein K; Huang J; Lasho T; Pardanani A; Mesa RA; Williamson CM; Ketterling RP; Hanson CA; Van Dyke DL; Tefferi A
Eur J Haematol; 2009 Apr; 82(4):255-9. PubMed ID: 19215287
[TBL] [Abstract][Full Text] [Related]
17. Primary chronic myelofibrosis: clinical and prognostic evaluation in 336 Japanese patients.
Okamura T; Kinukawa N; Niho Y; Mizoguchi H
Int J Hematol; 2001 Feb; 73(2):194-8. PubMed ID: 11372731
[TBL] [Abstract][Full Text] [Related]
18. Age and platelet count are IPSS-independent prognostic factors in young patients with primary myelofibrosis and complement IPSS in predicting very long or very short survival.
Patnaik MM; Caramazza D; Gangat N; Hanson CA; Pardanani A; Tefferi A
Eur J Haematol; 2010 Feb; 84(2):105-8. PubMed ID: 19895568
[TBL] [Abstract][Full Text] [Related]
19. Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival.
Rupoli S; Da Lio L; Sisti S; Campanati G; Salvi A; Brianzoni MF; D'Amico S; Cinciripini A; Leoni P
Ann Hematol; 1994 Apr; 68(4):205-12. PubMed ID: 8003563
[TBL] [Abstract][Full Text] [Related]
20. Idiopathic myelofibrosis (agnogenic myeloid metaplasia): clinicopathological analysis of 32 patients.
Ozen S; Ferhanoğlu B; Senocak M; Tüzüner N
Leuk Res; 1997 Feb; 21(2):125-31. PubMed ID: 9112429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
